Bethenny Frankel proves she’s summer body ready in jungle-themed swimsuit

Bethenny Frankel continues to show fans she’s already ready for the beach body of summer — as she stepped into yet another form-fitting swimsuit in Miami on Monday.

The 52-year-old reality star and businesswoman – who has spoken out about Ozempic for weight loss – showed off her toned legs in the stunning bathing suit, which also showed off her cleavage.

On the ride, her fiancé Paul Bernon was with them as they grabbed each other on the PDA, holding hands as they headed to the beach together.

Former Real Housewives star Bethenny showed off her wild side for the outing, rocking a jungle-themed one-piece with a graphic print of two tigers.

The mum-of-one, who shares daughter Bryn, 12, with ex Jason Hoppy, added a white hat and matching sunglasses to her ensemble.

Bethenny and Paul, a film and TV producer, met in 2018 through a dating app.

The co-founder of Forever Young Rosé was married to her ex-husband Jason for 11 years.

Bethenny’s beach day comes after the outspoken multihyphenate spoke out against the diabetes drug Ozempic.

Although Ozempic was created to treat type 2 diabetes, the satiety side effect has taken Hollywood by storm as a “quick fix” for shedding unwanted pounds.

“People don’t want to give in [they use Ozempic] but they want people to believe it was blood, sweat and tears [that led to their weight loss],” Skinnygirl’s CEO said on social media earlier this month.

“The loophole for people avoiding the Ozempic confession is that many celebrities are actually using Mounjaro, another drug [also used to treat diabetes]and more new drugs are coming soon,” she claimed in her post’s caption.

She compared the drug’s popularity to that of earlier fads like Ephedra (Ma Huang) which gained popularity in the late ’90s but was later banned by the FDA after supplements containing the ingredient were found to pose serious health risks.

‘So [Ozempic] is now an apparently positive drug that will alleviate obesity. The problem is that it’s for diabetes and they sell it in Mexican pharmacies and airports,” Bethenny added.

She also claimed she had heard that the drug – which is given as weekly injections for $1,000 a month – is also a “mood-alterer” that causes “irrational” behavior in those who take it.

Bethenny kicked off the conversation by addressing the common questions and concerns surrounding the use of Ozempic, as well as criticism that many are “taking the easy way” by using it to achieve their weight loss goals.

While there are other “shortcuts” to weight loss, such as gastric bypass surgery and the lap band, those surgeries are only available to people with a BMI of 30 or higher.

While off-label semaglutide – the active ingredient in Ozempic and Wegovy – is easily accessible regardless of BMI.

Bethenny said she’s heard the drug is “running like crazy” in affluent communities like Florida’s Boca Raton and New York City’s Upper West Side.